Sponsored by:

Molecular Imaging: Page 285

EU's CHMP offers positive opinion on Amyvid
By AuntMinnie.com staff writers
Europe's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Amyvid (florebetapir F-18) for injection as a PET radiotracer to detect beta-amyloid neuritic plaque in patients with cognitive impairment, according to Eli Lilly and its subsidiary Avid Radiopharmaceuticals.
October 18, 2012
MILabs awarded U-SPECT/CT contract
By AuntMinnie.com staff writers
Preclinical molecular imaging developer MILabs has taken an order for its U-SPECT/CT system from the BC Cancer Agency in Vancouver, British Columbia, to expand its molecular oncology imaging and research capabilities.
October 17, 2012
MILabs debuts SPECT system
By AuntMinnie.com staff writers
Preclinical molecular imaging developer MILabs has developed U-SPECT Quick Start (U-SPECTQS), a molecular imaging system targeted at research institutions.
October 17, 2012
Jubilant DraxImage taps CMO
By AuntMinnie.com staff writers
Radiopharmaceutical firm Jubilant DraxImage has named Dr. Norman LaFrance as vice president, medical and regulatory affairs, and chief medical officer (CMO).
October 16, 2012
Positron wins solid-state detector patent
By AuntMinnie.com staff writers
PET vendor Positron has received a patent from the U.S. Patent and Trademark Office for solid-state semiconductor detector technology used in precision measuring of coordinates and detection of ionization particles.
October 15, 2012
PiB-PET better than genetic factor in showing Alzheimer's risk
By Wayne Forrest
PET imaging with carbon-11-labeled Pittsburgh Compound B has revealed that high amounts of beta-amyloid plaque in the brain may be a better predictor of future memory loss in mentally healthy older people than the APOE ε4 allele, according to a study in the October 16 issue of Neurology.
October 15, 2012
Positron gets final nod on strontium-82 project
By AuntMinnie.com staff writers
PET vendor Positron said that its Manhattan Isotope Technology subsidiary officially entered the radiopharmaceutical production business with final sign-off on the project from the U.S. Food and Drug Administration.
October 9, 2012
Challenges remain for Gamma Medica after bankruptcy filing
By Wayne Forrest
The clock is now ticking for molecular breast imaging (MBI) developer Gamma Medica, which has three months to find additional financing or reorganize itself after a bankruptcy court approved a temporary financing plan last week. The outcome could impact the nascent market for MBI technology.
October 9, 2012
2012 10 10 08 53 35 288 Luma Gem Thumb
ImaginAb teams with Danish pharma firm
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb has inked a collaboration and commercialization agreement with Danish pharmaceutical firm H. Lundbeck.
October 8, 2012
Monarch PET/CT now offers Amyvid PET scans
By AuntMinnie.com staff writers
Diagnostic imaging service provider Monarch PET/CT announced that it is now offering PET/CT exams using the radiopharmaceutical Amyvid at some of its facilities.
October 8, 2012
Gamma Medica gets bankruptcy financing
By AuntMinnie.com staff writers
Gamma Medica has received approval from U.S. Bankruptcy Court for the Central District of California for $1.5 million debtor-in-possession financing as part of the company's Chapter 11 restructuring.
October 7, 2012
Rubidium PET edges SPECT in diagnosing coronary artery disease
By Wayne Forrest
PET imaging with the rubidium-82 radiotracer can accurately detect obstructive coronary artery disease and is superior to technetium-99m SPECT imaging, according to a meta-analysis published online October 3 by the Journal of the American College of Cardiology.
October 4, 2012
Previous Page
Page 285 of 611
Next Page